Hoffmann-La Roche Inc. isn’t liable on a woman’s claims that Accutane, the company’s medication for chronic acne, caused her severe bowel disease, the Nebraska Supreme Court ruled May 18.
The trial court’s exclusion of an expert witness for Aimee Freeman was proper because his opinion on the link between Accutane and her Crohn’s disease was unreliable, the unanimous court said. That entitled the company to a summary judgment.
The expert, David Sachar, ignored all but one epidemiological study that found no significant link between Accutane, or isotretinoin, and inflammatory bowel disease, the court said.
His opinion also clashed with those ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.